These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

111 related articles for article (PubMed ID: 422693)

  • 21. Acute intermittent porphyria: pathophysiology and treatment.
    Khanderia U; Bhattacharya A
    Pharmacotherapy; 1984; 4(3):144-50. PubMed ID: 6377248
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Treatment of acute intermittent porphyria with a new protein-bound lyophilized hematin].
    Fuchs T; Ippen H
    Dtsch Med Wochenschr; 1987 Aug; 112(34):1302-5. PubMed ID: 3622268
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Prognosis of acute porphyria: occurrence of acute attacks, precipitating factors, and associated diseases.
    Kauppinen R; Mustajoki P
    Medicine (Baltimore); 1992 Jan; 71(1):1-13. PubMed ID: 1549056
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Acute intermittent porphyria.
    O'Connor LJ
    Am J Nurs; 1981 Jun; 81(6):1184-6. PubMed ID: 6909012
    [No Abstract]   [Full Text] [Related]  

  • 25. Porphobilinogen deaminase over-expression in hepatocytes, but not in erythrocytes, prevents accumulation of toxic porphyrin precursors in a mouse model of acute intermittent porphyria.
    Unzu C; Sampedro A; Mauleón I; Vanrell L; Dubrot J; de Salamanca RE; González-Aseguinolaza G; Melero I; Prieto J; Fontanellas A
    J Hepatol; 2010 Mar; 52(3):417-24. PubMed ID: 19815305
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Hyperinsulinemia in acute intermittent porphyria.
    Sixel-Dietrich F; Verspohl F; Doss M
    Horm Metab Res; 1985 Jul; 17(7):375-6. PubMed ID: 3897010
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Treatment of cyclic attacks of acute intermittent porphyria with an LH-RH agonist administered by the intranasal route].
    Semon C; Dupond JL; Mallet H; Grandmottet-Cambefort C; Humbert P
    Ann Endocrinol (Paris); 1986; 47(5):399-402. PubMed ID: 3103522
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Alterations in haem biosynthesis during the human menstrual cycle: studies in normal subjects and patients with latent and active acute intermittent porphyria.
    McColl KE; Wallace AM; Moore MR; Thompson GG; Goldberg A
    Clin Sci (Lond); 1982 Feb; 62(2):183-91. PubMed ID: 7053917
    [No Abstract]   [Full Text] [Related]  

  • 29. Acute intermittent porphyria in childhood: a population-based study.
    Hultdin J; Schmauch A; Wikberg A; Dahlquist G; Andersson C
    Acta Paediatr; 2003 May; 92(5):562-8. PubMed ID: 12839285
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Awareness is the name of the game: clinical and biochemical evaluation of a case of a girl diagnosed with acute intermittent porphyria associated with autism.
    Luder AS; Mamet R; Farbstein I; Schoenfeld N
    Cell Mol Biol (Noisy-le-grand); 2009 Feb; 55(1):19-22. PubMed ID: 19267997
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Postulated deficiency of hepatic heme and repair by hematin infusions in the "inducible" hepatic porphyrias.
    Watson CJ; Pierach CA; Bossenmaier I; Cardinal R
    Proc Natl Acad Sci U S A; 1977 May; 74(5):2118-20. PubMed ID: 266732
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Acute attacks of hepatic porphyria. Treatment with hematin. 5 cases].
    Devars du Mayne JF; Deybach JC; Phung L; Likforman J; Tenhunen R; Cerf M; Nordmann Y
    Presse Med; 1986 Oct; 15(33):1673-6. PubMed ID: 2947113
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Plasma porphobilinogen as a sensitive biomarker to monitor the clinical and therapeutic course of acute intermittent porphyria attacks.
    Sardh E; Harper P; Andersson DE; Floderus Y
    Eur J Intern Med; 2009 Mar; 20(2):201-7. PubMed ID: 19327613
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Danazol: an alternative in postcoital contraception].
    Pejrani G; Tessari S
    Minerva Ginecol; 1989 Jan; 41(1):33-4. PubMed ID: 2739938
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The porphyrias.
    Moore MR; McColl KE; Goldberg A
    Diabete Metab; 1979 Dec; 5(4):323-36. PubMed ID: 398301
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Acute intermittent porphyria. Detection of asymptomatic carriers of the genetic defect].
    Grandchamp B; Grelier M; Nordmann Y
    Nouv Presse Med; 1975 Jun; 4(24):1801-2. PubMed ID: 1161481
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Danazol, a new steroidal inducer of delta-aminolevulinic acid synthetase.
    Hughes MJ; Rifkind AB
    J Clin Endocrinol Metab; 1981 Mar; 52(3):549-52. PubMed ID: 7462405
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Manifestation of acute intermittent porphyria in patients with chronic inflammatory bowel disease.
    Sieg I; Beckh K; Kersten U; Doss MO
    Z Gastroenterol; 1991 Nov; 29(11):602-5. PubMed ID: 1771936
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Evaluation of gonadotropin-releasing hormone agonist treatment for prevention of menstrual-related attacks in acute porphyria.
    Innala E; Bäckström T; Bixo M; Andersson C
    Acta Obstet Gynecol Scand; 2010; 89(1):95-100. PubMed ID: 20021268
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Diagnostic and therapeutic problems in acute intermittent porphyria].
    Mühler E
    Nervenarzt; 1976 Feb; 47(2):126-9. PubMed ID: 1256621
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.